USPTO serial 76210655
CELLECTIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 10, 2004
- Examiner
- CHARLON, BARNEY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with CELLECTIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
Mary Margaret L. O'Donnell Blue Filament Law PLLC772 E. Maple RoadBirmingham, MI 48009United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical, biotechnological products intended for industry, agriculture, horticulture, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; ready to use genomic recombination system, namely, meganuclease recombination agents for use in genetic engineering of cells and animals, namely rodent and fish , for scientific, laboratory or medical research; chemical, biochemical, biotechnological and bacteriological products intended for research laboratories and control laboratories, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for use in connection with cells and animals for scientific, laboratory or medical research; chemical, biochemical, biotechnological products and bacteriological preparations for sciences, namely polypeptides for in vivo and in vitro genetic engineering; natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for use in connection with cells and animals for scientific, laboratory or medical research; diagnostic preparation, namely natural and engineered meganucleases and endonucleases, molecular scissors for scientific or research use; proteins as raw materials; microorganisms used for producing therapeutical compounds or vaccines; chemical and biochemical preparations for medical, pharmaceutical and veterinary use, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination agents for scientific or research use | ACTIVE | — |
| 005 | Pharmaceutical, veterinary and health-care products, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system, cells engineered by meganulease recombination system for use in genetic or viral diseases; microorganism cultures and preparation for medical, pharmaceutical and veterinary use, namely microoganisms engineered by meganuclease recombination system for use in genetic or viral diseases, cancers and vaccines; microorganisms producing polypeptides for in vivo and vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system for use in genetic or viral diseases; bacteriological preparations for medical, pharmaceutical and veterinary use namely bacteriological preparations engineered by meganuclease recombination system; bacteriological preparations producing polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors, ready to use genomic recombination system; drugs for veterinary use, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic and acid vectors, molecular scissors for use in genetic or viral diseases; biological preparation for medical, pharmaceutical and veterinary use namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleaes, nucleic and vectors, molecular scissors, ready to use genomic recombination system, cells engineered by meganuclease recombination system for use in genetic or viral diseases; chemopharmaceutical preparations; diagnostic preparations for clinical or medical laboratory use | ACTIVE | — |
| 009 | [ Scientific devices and instruments enabling implementation of biochemical analysis techniques and molecular biology techniques, namely automated biochemical analyser, automated protein production and protein purification devices, biochemical, biological automated assay devices, nucleic acid break analyser, analyzer for automatically measuring and researching interactions of biomolecules, device for protein-nucleic acid interaction analysis; apparatus for use in analysis and array-tests, qualitative and quantitative detection of analytes in samples, namely, DNA sequencing, receptor-ligand interaction, protein analysis, mass-spectrometry, nucleic acid hybridization and detection, thermo-cycler systems, microarray-printer, microarray-reader; scientific devices and instruments enabling the mapping of the biological activities of all molecules; information processing equipment, namely, computer software for molecular design, sequence analysis, sequence generation, design and analysis for molecules, namely polypeptides or polynucleotides used in genetic engineering, design and analysis of meganucleases and endonucleases and for design and analysis of genetic recombination systems, hardware and component parts, namely, processors, memory banks, peripheral controllers; multimedia products, namely, prerecorded magnetic tapes, CD-ROMs, containing image and sound recordings in the fields of chemistry, biology, biochemistry, molecular biology, bacteriology; software programs namely, software for providing an on-line computer database in the field of pharmaceuticals and biotechnology; software for searching, retrieving, storing, maintaining and managing data in the field of pharmaceuticals and biotechnology; software for use in the field of scientific information management; software for use in drug discovery; software for biomolecules analysis, nucleic acids and proteins sequences evaluation, chemical, medical and biological data bank searches and analysis, physiological data analysis, genetic data analysis, chemical formulae analysis, structural prediction for biological and chemical molecules; software for writing biological molecule sequence; molecular design software for analysis, simulation and design of biological, chemical, and material systems; software for molecular design in the biotechnology and pharmaceutical field; software for use in biological and chemical modeling, analysis and information management; software for integrated global management ] | SECTION 8 - CANCELLED | — |
| 042 | Scientific and industrial research; research in genetic, medical, pharmaceutical and veterinary fields; research in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis; research and development for others of techniques of biochemical analysis, biological analysis, molecular biology techniques; research and development for others of new molecules intended for industry; laboratory research in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; medical services; studies of technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology, agriculture; testing, analysis and evaluation of engineering works for others; licensing of patents and intellectual property; computer programming for others, development for others of multimedia software programs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cellectis S.A.
- Other trademarks owned by Cellectis S.A.
- Other trademarks owned by Cellectis S.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named CELLECTIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 13, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 13, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 13, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 13, 2024 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Nov 13, 2024 | RNL2 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Nov 13, 2024 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Nov 10, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 12, 2024 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Oct 18, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 18, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 18, 2023 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Oct 18, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 18, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 18, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 10, 2023 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Feb 12, 2015 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Feb 12, 2015 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Feb 12, 2015 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Feb 10, 2015 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Feb 10, 2015 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 10, 2015 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 27, 2010 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 27, 2010 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 6, 2010 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Aug 6, 2010 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Aug 10, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 1, 2004 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 26, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| May 26, 2004 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 21, 2004 | CFIT | CASE FILE IN TICRS | — |
| May 11, 2004 | IUAF | USE AMENDMENT FILED | — |
| May 11, 2004 | FAXX | FAX RECEIVED | — |
| May 11, 2004 | PAPER RECEIVED | — | |
| Dec 9, 2003 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 13, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 13, 2003 | PAPER RECEIVED | — | |
| May 13, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 18, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 29, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 16, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 22, 2002 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Nov 21, 2002 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 21, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 30, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2002 | PAPER RECEIVED | — | |
| May 20, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 21, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 19, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 15, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2001 | DOCK | ASSIGNED TO EXAMINER | — |